
Primary Infertility — Evaluate the Couple & Treat the Cause
Infertility is no pregnancy after 12 months of regular, unprotected intercourse; it is “primary” when she has never conceived [1] (from memory)
It affects 8 to 12% of couples of reproductive age worldwide [1]
Female factors in 35 to 50%, male factors in 40 to 50%, unexplained in up to 30%; many couples have more than one [1]
Evaluate both partners at the same time; get a semen analysis at the start [2]
Start at 12 months if she is under 35, at 6 months if 35 or older, and at once if over 40 or a cause is known [1][2]
Her age is the single most important predictor of fertility [2]
Four questions: is she ovulating, are the tubes open, is the uterus normal, is the semen normal?
| Her | Him |
|---|---|
| Menstrual pattern: 25 to 35-day cycles usually mean ovulation [2] | Previous fertility, mumps, undescended testis, groin or scrotal surgery (from memory) |
| Pelvic infection, surgery, dysmenorrhoea, dyspareunia [1][2] | Erectile or ejaculatory problems; coital frequency |
| Hirsutism, acne, galactorrhoea, thyroid symptoms [1][2] | Tobacco, alcohol, cannabis, anabolic steroids, heat exposure [1] (from memory) |
| Medicines, including retinoids, valproate, warfarin, lithium [1] | Medicines and long-term illness |
| BMI, thyroid, breasts and pelvic examination [1] | BMI; testicular size, vas deferens, varicocele (from memory) |
Tuberculosis: ask about past disease or contact; genital tuberculosis is an important cause of tubal and endometrial damage in India (from memory)
| Question | Test | Reading |
|---|---|---|
| Is she ovulating? | Menstrual history; luteal progesterone | Over 3 ng/mL confirms recent ovulation [2] |
| Ovarian reserve | AMH, antral follicle count, day 2 to 4 FSH | Low reserve: AMH under 1.0 ng/mL, count under 5 to 7, FSH over 10 [1] |
| Are the tubes open? | HSG or HyCoSy | HSG sensitivity 65%, specificity 83% against laparoscopy [2] |
| Is the uterus normal? | Transvaginal ultrasound; sonohysterography | Abnormal in 16.2%: mostly polyps [2] |
| Is the semen normal? | Semen analysis | See the table below |
| Prolactin, TSH | Only if indicated | Irregular cycles, galactorrhoea, thyroid symptoms [2] |
Ovarian reserve tests predict the response to treatment, not natural fertility; do not use them to refuse treatment [1][2]
A one-sided proximal block on HSG is a false finding in over 40%; confirm before acting [2]
| Semen parameter | Lower reference limit (WHO 2021) [3] |
|---|---|
| Volume | 1.4 mL |
| Total sperm number | 39 million per ejaculate |
| Concentration | 16 million per mL (from memory) |
| Total motility | 42% |
| Progressive motility | 30% |
| Normal forms | 4% |
| Vitality | 54% |
One abnormal result should be repeated before a diagnosis is made (from memory)
Laparoscopy for unexplained infertility [2]
Postcoital test and endometrial biopsy [2]
Basal body temperature charts [2]
Thrombophilia, immunological tests and karyotype [2]
Sperm DNA fragmentation and other advanced sperm tests [2]
Repeated AMH measurements [2]
Weight: loss of 5 to 10% restores ovulation and improves the response to drugs in women with obesity [1]
Stop tobacco and other drugs; keep alcohol under two drinks a day [1]
Diet: folic acid, vitamins D and B12, fruit, vegetables and fish [1]
Intercourse every 1 to 2 days around the fertile window; no need for rigid timing (from memory)
Folic acid 400 micrograms daily, and check rubella immunity and haemoglobin before conception (from memory)
| Cause | Treatment [1] |
|---|---|
| PCOS, anovulation | Lifestyle change; letrozole 2.5 to 7.5 mg daily on cycle days 3 to 7; letrozole reaches pregnancy sooner than clomiphene |
| Clomiphene | 50 mg daily for 5 days from cycle day 2 to 5; increase to 100 mg |
| High prolactin; hypothyroidism | Dopamine agonist; thyroxine |
| Tubal disease | Tubal surgery or IVF; refer |
| Uterine cavity lesion | Hysteroscopic surgery; refer |
| Male factor | IUI, IVF or donor sperm; surgery for obstruction |
| Low ovarian reserve | Early referral; donor eggs may be needed |
| Unexplained | Letrozole or clomiphene with IUI: live birth 31% vs 9% with waiting over 3 cycles; IVF if 38 or older |
Refer if there is no pregnancy after 6 ovulatory cycles on treatment [1]
Gonadotrophins carry risks of ovarian hyperstimulation and multiple pregnancy; specialist use only [1]
See the couple together; infertility is a shared problem and men contribute in up to half [1][2]
Give a time plan: what will be tried, for how long, and when referral follows
Cost is a major reason couples stop treatment; discuss it early [1]
Emotional distress is common; ask about it and about pressure from family (from memory)
Assisted reproduction in India must be done in a clinic registered under the ART Act 2021 (from memory)
Investigating only the woman [2]
Waiting a year in a woman over 35 or with irregular cycles [1][2]
Repeated ovulation induction without knowing the tubes and semen
Treating an AMH value as a verdict on natural fertility [1][2]
Day-21 progesterone in a 35-day cycle; time it from the expected period [2]
Routine laparoscopy or a battery of hormone tests [2]
Delaying referral after 6 failed cycles [1]
COUPLE
| Abbreviation | Meaning |
|---|---|
| AMH | Anti-Müllerian hormone; a marker of ovarian reserve |
| ART | Assisted reproductive technology |
| ASRM | American Society for Reproductive Medicine |
| BMI | Body mass index |
| FSH | Follicle-stimulating hormone |
| HSG | Hysterosalpingography; an X-ray dye test of the uterus and tubes |
| HyCoSy | Hysterosalpingo-contrast sonography; an ultrasound test of the tubes |
| IUI | Intrauterine insemination |
| IVF | In vitro fertilisation |
| LH | Luteinising hormone |
| PCOS | Polycystic ovary syndrome |
| TSH | Thyroid-stimulating hormone |
| WHO | World Health Organization |
[1] Phillips K, Olanrewaju RA, Omole F. Infertility: evaluation and management. Am Fam Physician 2023;107(6):623-630.
[2] Practice Committee of the American Society for Reproductive Medicine. Fertility evaluation of infertile women: a committee opinion. Fertil Steril 2026 (volume and pages not yet assigned; replaces Fertil Steril 2021;116:1255-65).
[3] World Health Organization. WHO laboratory manual for the examination and processing of human semen, 6th edition. Geneva: WHO; 2021. (Values read from the MSD Manual Professional table that cites it.)



